Central Nervous System Agents
A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into specific agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and nonspecific agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252)
Subtype terms (16)
More specific conditions that are subtypes of Central Nervous System Agents in the MeSH hierarchy.
- Abuse-Deterrent Formulations
- Adjuvants, Anesthesia
7 drugs approved
- Alcohol Deterrents
- Analgesics
35 drugs (30 approved, 5 experimental)
- Anticonvulsants
1 drug approved
- Anti-Dyskinesia Agents
1 drug experimental
- Antiemetics
9 drugs (8 approved, 1 experimental)
- Antitussive Agents
- Central Nervous System Depressants
10 drugs approved
- Central Nervous System Stimulants
12 drugs (11 approved, 1 experimental)
- Emetics
- Muscle Relaxants, Central
9 drugs approved
- Narcotic Antagonists
1 drug approved
- Neuroprotective Agents
2 drugs (1 approved, 1 experimental)
- Nootropic Agents
- Psychotropic Drugs
6 drugs (5 approved, 1 experimental)
Drugs by status
Phase 3 trials (1)
Phase 1 trials (1)